Risks Associated with Sjögren's Syndrome
Patients with Sjögren's syndrome are at significantly increased risk of developing non-Hodgkin lymphoma (10-44 times higher risk than the general population), particularly marginal zone B-cell lymphomas affecting the salivary glands. 1
Major Complications and Risks
Lymphoproliferative Disorders
- Non-Hodgkin Lymphoma (NHL)
- Most serious complication with 10-44 fold increased risk compared to healthy individuals 1
- Predominantly low-grade B-cell lymphomas of marginal zone histological type 1
- Primary extranodal involvement of major salivary glands, especially parotid 1
- Diffuse large B-cell lymphoma is the most common NHL subtype 2
- Risk factors include presence of cryoglobulinemia and higher EULAR Sjögren's syndrome disease activity index 1
Organ-Specific Complications
Oral/Dental Complications
Ocular Complications
Pulmonary Manifestations
Renal Complications
Neurological Complications
Other Associated Conditions
Thyroid Cancer
- Increased risk compared to general population 4
Multiple Myeloma
- Higher incidence in Sjögren's patients 4
Skin Cancers
- Elevated risk reported in some studies 4
Other Autoimmune Conditions
Risk Stratification and Monitoring
High-Risk Factors for Lymphoma Development
- Presence of cryoglobulinemia 1
- Elevated disease activity (high EULAR Sjögren's syndrome disease activity index) 1
- Salivary gland enlargement 3
- Persistent parotid enlargement 3
Protective Factors
- Salivary gland biopsies appear to be associated with lower lymphoma risk 2
- Immunomodulator therapy (hydroxychloroquine, azathioprine, cyclosporine, methotrexate, rituximab) may reduce lymphoma risk 2
Recommended Monitoring
- Regular monitoring for lymphoproliferative disorders 3
- Pulmonary function tests for respiratory complications 3
- Vigilance for vasculitic manifestations 3
- Thyroid function monitoring 3
- In pregnant women with anti-Ro antibodies, fetal echocardiography between 16-26 weeks to monitor for congenital heart block 3
Clinical Pearls
- The risk of lymphoma in Sjögren's syndrome exceeds that seen in other autoimmune diseases like systemic lupus erythematosus and rheumatoid arthritis 1
- Some lymphomas in Sjögren's syndrome may evolve slowly or even regress spontaneously 6
- Multiple risk factors in an individual correlate with higher lymphoma risk 1
- Co-management with a rheumatologist is essential due to potential systemic complications 3